Targeting adipokines: A new strategy for the treatment of myocardial fibrosis

Cardiac fibrosis is a pathogenic factor of many cardiovascular diseases (CVD), which seriously affects people's life and health, causing huge economic losses.Therefore, it is very significant to find an effective treatment for myocardial fibrosis. Adipokines are mainly derived from adipose tiss...

Full description

Bibliographic Details
Main Authors: Xiaoying Han, Yi Zhang, Xinyu Zhang, Haixia Ji, Wenzhe Wang, Ou Qiao, Xia Li, Juan Wang, Changxiao Liu, Luqi Huang, Wenyuan Gao
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S104366182200202X
_version_ 1797366672753950720
author Xiaoying Han
Yi Zhang
Xinyu Zhang
Haixia Ji
Wenzhe Wang
Ou Qiao
Xia Li
Juan Wang
Changxiao Liu
Luqi Huang
Wenyuan Gao
author_facet Xiaoying Han
Yi Zhang
Xinyu Zhang
Haixia Ji
Wenzhe Wang
Ou Qiao
Xia Li
Juan Wang
Changxiao Liu
Luqi Huang
Wenyuan Gao
author_sort Xiaoying Han
collection DOAJ
description Cardiac fibrosis is a pathogenic factor of many cardiovascular diseases (CVD), which seriously affects people's life and health, causing huge economic losses.Therefore, it is very significant to find an effective treatment for myocardial fibrosis. Adipokines are mainly derived from adipose tissue and have an prominent regulatory effect on glucose and lipid metabolism, inflammation, immune response and cardiovascular function. Adipose tissue is composed of a variety of cell types, including adipocytes, endothelial cells, macrophages and smooth muscle cells. Adipokines mainly include adiponectin, leptin, resistin, visfatin and omentin, which are synthesized and secreted by adipocytes. More and more evidence shows that adipokines can regulate the progress of cardiac fibrosis. This scientific review provides new ideas for targeting adipokines in the treatment of myocardial fibrosis and provides strategies for the development of new, safe, and effective pharmacological antagonists against myocardial fibrosis based on adipokines activity.
first_indexed 2024-03-08T17:07:03Z
format Article
id doaj.art-8cabdbefcf454e66945281dfc3414b5e
institution Directory Open Access Journal
issn 1096-1186
language English
last_indexed 2024-03-08T17:07:03Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj.art-8cabdbefcf454e66945281dfc3414b5e2024-01-04T04:37:37ZengElsevierPharmacological Research1096-11862022-07-01181106257Targeting adipokines: A new strategy for the treatment of myocardial fibrosisXiaoying Han0Yi Zhang1Xinyu Zhang2Haixia Ji3Wenzhe Wang4Ou Qiao5Xia Li6Juan Wang7Changxiao Liu8Luqi Huang9Wenyuan Gao10School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR ChinaTianjin Pharmaceutical Research Institute, Tianjin 300072, PR ChinaNational Resource Center for Chinese Materia Medica, Chinese Academy of Chinese Medical Sciences, Beijing, PR ChinaSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR China; Corresponding author.Cardiac fibrosis is a pathogenic factor of many cardiovascular diseases (CVD), which seriously affects people's life and health, causing huge economic losses.Therefore, it is very significant to find an effective treatment for myocardial fibrosis. Adipokines are mainly derived from adipose tissue and have an prominent regulatory effect on glucose and lipid metabolism, inflammation, immune response and cardiovascular function. Adipose tissue is composed of a variety of cell types, including adipocytes, endothelial cells, macrophages and smooth muscle cells. Adipokines mainly include adiponectin, leptin, resistin, visfatin and omentin, which are synthesized and secreted by adipocytes. More and more evidence shows that adipokines can regulate the progress of cardiac fibrosis. This scientific review provides new ideas for targeting adipokines in the treatment of myocardial fibrosis and provides strategies for the development of new, safe, and effective pharmacological antagonists against myocardial fibrosis based on adipokines activity.http://www.sciencedirect.com/science/article/pii/S104366182200202XAdipokinesCardiac fibrosisCardiovascular dysfunctionAngiotensin systemStrategies
spellingShingle Xiaoying Han
Yi Zhang
Xinyu Zhang
Haixia Ji
Wenzhe Wang
Ou Qiao
Xia Li
Juan Wang
Changxiao Liu
Luqi Huang
Wenyuan Gao
Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
Pharmacological Research
Adipokines
Cardiac fibrosis
Cardiovascular dysfunction
Angiotensin system
Strategies
title Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
title_full Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
title_fullStr Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
title_full_unstemmed Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
title_short Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
title_sort targeting adipokines a new strategy for the treatment of myocardial fibrosis
topic Adipokines
Cardiac fibrosis
Cardiovascular dysfunction
Angiotensin system
Strategies
url http://www.sciencedirect.com/science/article/pii/S104366182200202X
work_keys_str_mv AT xiaoyinghan targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT yizhang targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT xinyuzhang targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT haixiaji targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT wenzhewang targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT ouqiao targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT xiali targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT juanwang targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT changxiaoliu targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT luqihuang targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis
AT wenyuangao targetingadipokinesanewstrategyforthetreatmentofmyocardialfibrosis